Home > Insider Trading > Filing (0001438133-20-000017)

Filing Details

Accession Number:: 0001438133-20-000017
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-24 16:35:02
Reporting Period:: 2020-02-21

Accepted Time:: 2020-02-24 16:35:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365369	F John Sheridan	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121	President & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-21	30,000	$2.59	32,501	No	4	M	Direct
Common Stock	Disposition	2020-02-21	16,458	$87.39	16,043	No	4	S	Direct
Common Stock	Disposition	2020-02-21	12,842	$88.38	3,201	No	4	S	Direct
Common Stock	Disposition	2020-02-21	700	$89.62	2,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2020-02-21	30,000	$0.00	30,000	$2.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,667			No	4	M	Direct

Footnotes

Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 6, 2019, as amended on December 16, 2019.
The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $87.00 to $87.97. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $88.01 to $88.90. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $89.60 to $89.67. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.